# A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198

> **NCT04102462** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 764198
- **DRUG:** Matching placebo

## Key facts

- **NCT ID:** NCT04102462
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-29
- **Primary completion:** 2020-10-08
- **Final completion:** 2020-10-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102462, "A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04102462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*